🇪🇺 Velsipity in European Union

EMA authorised Velsipity on 21 February 2024

Marketing authorisations

EMA — authorised 21 February 2024

  • Local brand name: Velsipity
  • Status: approved

EMA

  • Status: approved

Velsipity in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Velsipity approved in European Union?

Yes. EMA authorised it on 21 February 2024; EMA has authorised it.

Who is the marketing authorisation holder for Velsipity in European Union?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.